Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Engineered Salmonella secreting heterologous bacterial flagellin suppress tumor growth by activating intratumoral macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
From The microbiome and human cancer (2021) · cites this paper as [152]
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 10×
“The in vitro stimulation of cancer cells with FlaB did not increase phosphorylation of NF-kB p65 (fig.”
BackgroundInfluentialThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“Cell preparation and FACS analysis Peritoneal macrophages were isolated from specific pathogen–free C57BL/6 male mice, as described previously (50).”
MethodToll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · cited 1×
“Because the background signals in experimental groupswere different, whichmay be due to different degrees of cell injury resulting from the different modes of treatment (PBS, empty Salmonella, and FlaB-secreting Salmonella), we adjusted gating parameters for the FACS analysis of different groups (51, 52).”
MethodTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“Because of accumulating reports that activating various TLRs resulted in antitumor effects (31, 37–41), many TLRspecific agonists are currently being investigated for tumor immunotherapy (37).”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“VNP20009, an attenuated strainof Salmonella typhimurium with purI and msbB gene deletions, was safely administered to patients with metastatic melanoma and renal cell carcinoma in a phase 1 study, where substantial tumor colonization was observed (11, 12).”
Research works printed but not linked: 1
- 10.1200/jco.2002.20.1.142 · DOI · Paper page
Cited by
Items 301–400 of 627
Gao, P., Duan, Z., Xu, G., Gong, Q., Wang, J., Luo, K., & Chen, J. (2024) · Advanced Materials · doi:10.1002/adma.202405075 · Cited by 18
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Yang, M., Zhong, P., & Wei, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052056 · Cited by 18
The multi-kingdom cancer microbiome
Dohlman, A. B., Pan, X., Zitvogel, L., & Iliev, I. D. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02103-7 · Cited by 19
Miyake, K., Kawaguchi, K., Miyake, M., Zhao, M. D., Kiyuna, T., Igarashi, K., Zhang, Z., Murakami, T., Li, Y., Nelson, S. D., et al. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00643 · Cited by 18
“Thus, tumor-targeting bacteria have great potential in curing solid tumors [88, 89, 90, 91, 92, 93, 94].”
BackgroundLiu, L., Wu, J., Gao, J., & Lu, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000893 · Cited by 18
Jia, X., Guo, J., Guo, S. J., Zhao, T., Liu, X., Cheng, C., Wang, L., Zhang, B., Meng, C., Jia, H., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107052 · Cited by 18
Unraveling the links between estrogen and gut microbiota in sex-hormone driven cancers
Tahri, A., & Amedei, A. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i9.108819 · Cited by 17
Akbariqomi, M., Zarandi, P. K., Abedi, A., Moghaddam, M. M., & Fooladi, A. A. I. (2025) · Microbial Cell Factories · doi:10.1186/s12934-025-02838-2 · Cited by 17
Lim, D., Jung, W. C., Jeong, J., & Song, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00840 · Cited by 17
Yang, S., Zhao, W., Zhu, M., Hu, H., Wang, W., Zang, Z., Jin, M., Bi, J., Huang, J., Liu, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712936 · Cited by 17
Highlights of Immunomodulation in Salmonella-Based Cancer Therapy
Pangilinan, C. R., & Lee, C. (2021) · Biomedicines · doi:10.3390/biomedicines9111566 · Cited by 17
“typhimurium SHJ2037 FlaB TLR5-dependent infiltration, and activation of immune cells thereafter MC38; B16F10 cells; TLR5–negative colon cancer cells TLR4−/−, TLR5−/−, and MyD88−/− KO mice (C57BL/6 genetic background) [79]”
BackgroundSeong, K.-J., Choi, S., Lee, H.-G., Rhee, J. H., Lee, J. H., Koh, J., Kim, S.-H., Choi, W., Jung, J., & Kim, W.-J. (2022) · Stem Cells · doi:10.1093/stmcls/sxab025 · Cited by 17
Self-citationSalmonella typhimurium may support cancer treatment: a review
Yang, Z., Zou, L., Yue, B., & Hu, M. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023007 · Cited by 17
“They showed similar effects in cancer suppression, while the ÄppGpp group had a higher rate of complete tumor eradication and longer survival time; and compared with the VNP20009 group, the levels of inflammatory cytokines of the ÄppGpp group were much higher in the TME, while those in circulation were lower [104].”
BackgroundInfluentialIncreasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori
Johnson, S. A., Ormsby, M. J., McIntosh, A., Tait, S. W. G., Blyth, K., & Wall, D. M. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0039-9 · Cited by 17
“Typhimuriummediated delivery of apoptotic proteins to tumour cells or overexpression of plasmid-encoded Vibrio vulnificus FlaB to slow tumour growth [9, 10].”
BackgroundLee, H. H., Hong, S. H., Rhee, J. H., & Lee, S. E. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2798 · Cited by 17
Self-citationZi, G., Zhou, W., Zhou, L., Wang, L., Zheng, P., & Wei, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101349 · Cited by 16
“…accuracy; elevated levels of TNF-α within the TME promote bacterial adhesion via induction of endothelial adhesion molecule expression, and stimulate matrix metalloproteinases to breakdown the extracellular matrix (ECM), thereby facilitating deep migration of bacteria into the tumor stroma [34].”
InfluentialGao, S., Yang, M., Xu, K., Jiang, X., Wu, X., & Wang, Y. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.738203 · Cited by 16
Zhang, L., & Yu, L. (2024) · Medicine · doi:10.1097/md.0000000000038078 · Cited by 16
“[91] The S typhimurium strains expressing IL-2 can enhance anti-tumor immune response by activating NK cells and CD8 T cells.”
BackgroundLi, X., Jia, Y., Li, Y., Hei, H., Zhang, S., & Qin, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582166 · Cited by 16
Monocytes mediate Salmonella Typhimurium ‐induced tumor growth inhibition in a mouse melanoma model
Johnson, S. A., Ormsby, M. J., Wessel, H. M., Hulme, H., Bravo‐Blas, A., McIntosh, A., Mason, S. M., Coffelt, S. B., Tait, S. W. G., Mowat, A. M., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202048913 · Cited by 16
“Other studies on bacterial-mediated cancer treatment have suggested a role for macrophages in mediating antitumor effects [3, 6].”
Methods of DNA introduction for the engineering of commensal microbes
Liu, D., Siguenza, N., Zarrinpar, A., & Ding, Y. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100048 · Cited by 16
“Similarly, electroporation has been used to engineer the gram-negative bacterium Salmonella typhimurium to secret heterologous flagellin, which enhances cancer immunotherapy [121] .”
Potential Effects of Regulating Intestinal Flora on Immunotherapy for Liver Cancer
Yan, X.-D., Bai, L., Qi, P., Lv, J., Song, X., & Zhang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411387 · Cited by 16
“This is evidenced by flagellar proteins secreted by Enterococcus gallinaurus and Salmonella typhimurium [68,69].”
BackgroundThe immunogenic potential of bacterial flagella for Salmonella‐mediated tumor therapy
Felgner, S., Spöring, I., Pawar, V., Kocijancic, D., Preuße, M., Falk, C. S., Rohde, M., Häußler, S., Weiß, S., & Erhardt, M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32807 · Cited by 16
McKenzie, N. D., Hong, H. S., Ahmad, S., & Holloway, R. W. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103165 · Cited by 16
Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives
Liu, J., He, C., Tan, W., & Zheng, J. H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122897 · Cited by 15
Self-citationThe Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy
Wang, C., Feng, Q., Shi, S., Qin, Y., Lu, H., Zhang, P., Liu, J., & Chen, B. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401538 · Cited by 15
Nano-armor modification of bacteria through supramolecular interactions for disease treatment
Cao, X., Wang, Y., Wang, Q., Huang, Y., Ding, Y., & Mao, Z. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216165 · Cited by 15
Pezeshki, B., Abdulabbas, H. T., Alturki, A. D., Mansouri, P., Zarenezhad, E., Nasiri‐Ghiri, M., & Ghasemian, A. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10462-0 · Cited by 15
Bacterial Systems as a Precision Delivery Platform of Therapeutic Peptides for Cancer Therapy
Liu, J., Shen, G., & Yan, X. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.4c00026 · Cited by 15
Prophylactic Vaccines for Nonviral Cancers
Scott, B., Yarchoan, M. M., & Jaffee, E. M. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050558 · Cited by 15
“In another combination study (Zheng et al. 2017), two-step enhancement of antitumor immunity was accomplished through two-step activation of TLR4 and TLR5.”
BackgroundReprogramming a Doxycycline-Inducible Gene Switch System for Bacteria-Mediated Cancer Therapy
Ngo, H. T.-T., Nguyen, D.-H., You, S.-H., Nguyen, K. V., Kim, S. Y., Hong, Y., & Min, J. (2023) · Molecular Imaging and Biology · doi:10.1007/s11307-023-01879-6 · Cited by 15
“Inducible promoters such as a bidirectional tetracycline-inducible (P tet ) [21, 22], arabinose-inducible araBAD (P BAD ) [10, 23], and lactose-inducible (P tac ) [24] promoters have been used to express therapeutic cargos in bacterial cancer therapy.”
Self-citationShirai, H., & Tsukada, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.024 · Cited by 15
Our Microbiome: On the Challenges, Promises, and Hype
Federici, S., Suez, J., & Elinav, E. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_20 · Cited by 15
Bacteria and macrophages in the tumor microenvironment
Xu, S. S., Xiong, Y., Fu, B., Guo, D. L., Sha, Z., Lin, X., & Wu, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1115556 · Cited by 14
Key role of exosomes derived from M2 macrophages in maintaining cancer cell stemness (Review)
Zhang, W., Zhou, R., Liu, X., You, L., Chen, C., Ye, X., Liu, J., & Liang, Y. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5574 · Cited by 14
“For example, TLR4 and TLR5 agonists have been observed to polarize a greater number of CD206+ M2 TAMs towards the CD86+ M1 phenotype, effectively suppressing tumor growth without significant toxicity (145).”
BackgroundSystematic review on the role of the gut microbiota in tumors and their treatment
Shi, Y., Li, X., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355387 · Cited by 14
“…proposed a method for using Salmonella to treat tumors, wherein the expression of Vibrio vulni fi cus fl agellin B by attenuated Salmonella can reduce immune suppression, alleviate subcutaneous colorectal tumors in mice, and inhibit tumor growth and metastasis, leading to an extended lifespan (80).”
MethodPotential applications of engineered bacteria in disease diagnosis and treatment
Luo, Z., Qi, Z., Luo, J., & Chen, T. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.57 · Cited by 14
Precision tumor treatment utilizing bacteria: principles and future perspectives
Liu, Z., Wang, L., Wu, P., & Yuan, L. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13378-x · Cited by 14
“Salmonella enterica subsp. enterica serovar ( S. typhimurium ) colonizing tumor induces upregulation of inducible nitric oxide synthase (iNOS), leading to a 1000-fold increase in NO production at micromolar levels within the tumor site (Barak et al. 2010; Cinelli et al. 2020; Zheng et al. 2017).”
Thiruppathi, J., Vijayan, V., Hwang, H. S., Bang, Y. J., Loeurng, V., Hong, S. H., Sundaram, A., Park, I., Lee, S. E., & Rhee, J. H. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010272 · Cited by 14
“32 40 Flagellin induces TLR5 expression of dLN DCs in a positive-feedback fashion.”
Self-citationNiu, X., Zhang, P., Dai, L., Peng, X., Liu, Z., Tang, Y., Zhang, G., & Wan, X. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010237 · Cited by 14
In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation
Shi, Y., Hou, Y., Mabrouk, M. T., Yu, C., & Yang, Y. (2025) · Advanced Science · doi:10.1002/advs.202509836 · Cited by 14
The gut-tumor connection: the role of microbiota in cancer progression and treatment strategies
Wei, Z., Gao, G., He, Q., Kwok, L. Y., & Sun, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.038 · Cited by 14
The influence of the gastrointestinal microbiome on colorectal metastasis: a narrative review
Stakelum, Á., Zaborowski, A. M., Collins, D., & Winter, D. C. (2020) · Colorectal Disease · doi:10.1111/codi.14930 · Cited by 14
Tian, S., Lin, G., Piao, L., & Liu, X. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02679-6 · Cited by 14
“Zheng et al. reported that the anti-tumor activity of S. t △ppGpp is mediated by the TLR4 pathway and activation of various other TLRs [25].”
BackgroundZhu, P., Zhou, C., Chen, J., Chu, Q., Li, F., Fu, Y., & Li, X. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214105 · Cited by 14
Zhang, Q., Dong, J., Wang, J., Wang, J., Wang, C., Li, Y., Chen, X. L., Wang, X., Shan, W., Fu, G., et al. (2023) · Small · doi:10.1002/smll.202301281 · Cited by 14
The potential use of theranostic bacteria in cancer
Azizian, K., Pustokhina, I., Ghanavati, R., Hamblin, M. R., Amini, A., & Kouhsari, E. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30152 · Cited by 14
“Zheng and colleagues engineered a genetically modified ΔppGpp S. typhimurium species that expressed and secreted the flagellin B (FlaB) molecule originating from Vibrio vulnificus, and tested it for cancer therapy in mice (Zheng et al., 2017).”
BackgroundInfluentialIntratumoral microorganisms in tumors of the digestive system
Xuan, M., Gu, X., Liu, Y., Li, Y., Li, Y., Huang, D., Li, J., & Xue, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01425-5 · Cited by 13
The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges
Zhang, R., Li, X., & Zhang, S. (2024) · Microorganisms · doi:10.3390/microorganisms12061053 · Cited by 13
“Zhou M et al. encapsulated EMB by detoxifying the outer membrane protein of E. coli (Omp@EMB) [72], which initiated cytophagy through activation of the membrane protein GRP94, facilitating the passage of the BBB, entry into brain metastatic breast cancer cells (BMBCCs), and releasing EMB (Figure 2).”
Jeon, H. J., Lim, D., So, E., Kim, S., Jeong, J., Song, M., & Lee, H. J. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.011 · Cited by 13
Du, M., Zeng, F., Wang, T., Fang, J., Chen, Y., Hou, L., Li, B., Xia, Q., Yuan, Z., Yan, F., et al. (2025) · Theranostics · doi:10.7150/thno.101714 · Cited by 13
“Chemical inducers [7, 8] are commonly used to regulate gene expression in engineered bacteria; however, they cannot be targeted to specific sites.”
Dong, P.-S., Zhou, Y., Yu, W., Zou, J.-H., Tian, Y., Fan, J., Zheng, D., & Zhao, Y. (2025) · Science China Materials · doi:10.1007/s40843-025-3438-6 · Cited by 13
“FlaB also triggers polarization of M1-like macrophages and promotes their production of cytokines and nitric oxide, which in turn exerts a tumor-suppressive effect [55].”
Pandey, P., & Khan, F. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130401 · Cited by 13
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers
Liu, Z., Hong, L., & Ling, Z. (2023) · Cancer Medicine · doi:10.1002/cam4.6298 · Cited by 13
Liu, L., Li, Q., Chen, C., Xin, W., Han, C., & Hua, Z. (2024) · iScience · doi:10.1016/j.isci.2024.109372 · Cited by 13
“…trial, VNP has been wildly used in drug delivery including carrying plasmids expressing therapeutic proteins such as anti-PD1 nanoantibod-ies or interferon-g , 17,20 cytotoxic protein, 21,22 cytokines or immune-modulators, 23,24 tumor vaccine, 25 or expressing shRNA against cancer-promoting genes.”
MethodZeng, Q., Zhang, S., Leng, N., & Xing, Y. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104576 · Cited by 13
Miyake, K., Kiyuna, T., Miyake, M., Zhao, M. D., Wangsiricharoen, S., Kawaguchi, K., Zhang, Z., Higuchi, T., Razmjooei, S., Li, Y., et al. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.09.001 · Cited by 13
Zahedifard, Z., Mahmoodi, S., & Ghasemian, A. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2738 · Cited by 12
Kato, A., Nomura, S., Takahashi, M., Sukowati, E. W., Harashima, H., & Mukai, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.064 · Cited by 12
Engineering smart bacteria for the next generation
Qiao, L., Wang, Z., Tang, S., Tian, J., Ye, H., & Cai, F. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102681 · Cited by 12
“10 To address this, synthetic biology-driven remote control systems have been developed, which integrate synthetic genetic circuits to regulate transgene expression in response to chemical inducers, 11 physical signals (e.g., heat 12 and light 13 ), or disease-specific biomarkers.”
Oxygen switches: Refueling for cancer radiotherapy
Li, X., Wang, H., Li, Z., Tao, F., Wu, J., Guan, W., & Liu, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1085432 · Cited by 12
“Genome editing may improve the safety and oxygengenerating capability of microorganisms-mediated photosynthesis (72).”
BackgroundSynthetic engineered bacteria for cancer therapy
Gong, T., & Wu, J. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2241367 · Cited by 12
“typhimurium LPS and FlaB elicited a robust innate immune response in which monocytes, macrophages, and neutrophils migrated toward the TME, and macrophages changed their phenotype from M2 to M1 and secreted cytokines [163] (figure 5a).”
BackgroundKiaheyrati, N., Babaei, A., Ranji, R., Bahadoran, E., Taheri, S., & Farokhpour, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122734 · Cited by 12
Zhuang, H., Wang, R., Qi, Y., Liu, Y., Xiong, H., & Yao, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.036 · Cited by 12
Stott, K. J., Phillips, B., Parry, L., & May, S. (2021) · Bioscience Reports · doi:10.1042/bsr20204113 · Cited by 12
Bacteria as Nanoparticle Carriers for Immunotherapy in Oncology
Moreno, V., & Baeza, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040784 · Cited by 12
“Some examples include the heterologous expression of cytokines such as IL-2 [80] or immunomodulatory proteins such as flagellin B [81].”
BackgroundBiological Roles of Toll-Like Receptors and Gut Microbiota In Colorectal Cancer
Wu, Y., Wu, W., Jing, Z., Zhou, Q., Yani, Z., & Han, S. (2022) · Future Microbiology · doi:10.2217/fmb-2021-0072 · Cited by 12
The Microbiome in Immuno-oncology
Toker, J. S., Arora, R., & Wargo, J. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41008-7_19 · Cited by 12
The Boosting Potential of Bacteria in Cancer Immunotherapy
Binder, D. C., & Wainwright, D. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.008 · Cited by 12
“Indeed, unsurpisingly, unmodified intravenous S. Typhimurium failed to control tumor progression (Binder et al., 2013; Zheng et al., 2017), and this lack of efficacy- even against immunogenic tumors- correlated with a lack of antitumor cytotoxic T cell responses (Binder et al., 2013).”
BackgroundInfluentialSeo, B., & Lim, M. Y. (2025) · Virulence · doi:10.1080/21505594.2025.2512035 · Cited by 11
“For instance, an engineered S. typhimurium strain that secretes Vibrio vulnificus fla-gellin B (VvFlaB) directly into tumours has been developed [124].”
InfluentialZuo, S., Ma, J., Li, X., Fan, Z., Li, X., Luo, Y., & Su, L. (2025) · Microorganisms · doi:10.3390/microorganisms14010073 · Cited by 11
“Engineered Salmonella that homes in on tumors and releases an IL-15/FlaB fusion protein exemplifies this concept, boosting antitumor immunity via TLR4/5 activation [173,174].”
Xu, Y., Wu, Y., Hu, Y., Xu, M., Liu, Y., Ding, Y., Chen, J., Huang, X., Wen, L., Li, J., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00363-0 · Cited by 11
Liu, Z., Lim, S.-H., Min, J., & Jung, S. (2023) · Vaccines · doi:10.3390/vaccines11071275 · Cited by 11
Self-citationGlycolytic reprogramming in macrophage polarization: New horizons in the treatment of tumor diseases
Wang, D., & Guan, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111940 · Cited by 10
Repurposing the bacterial surface display technology for drug delivery
Yang, S., Yang, M., Jennings, M., Timek, H., Haley, A. E., Romee, R., & Li, J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115701 · Cited by 10
Chong, A., Nguyen, D.-H., Kim, H. S., Chung, J., & Min, J. (2022) · Molecular Imaging · doi:10.1155/2022/9222331 · Cited by 10
Self-citationNie, C., Tao, F., Wang, P., Jiang, X., Peng, P., Yang, X., Wang, J., Yu, L., Guo, Y., & Peng, L. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154567 · Cited by 10
Research progress on intratumoral microorganisms in renal cancer
Zhang, J., Lou, K., Chi, J., Wu, J., Fan, X., & Cui, Y. (2025) · World Journal of Urology · doi:10.1007/s00345-024-05403-5 · Cited by 10
Yang, X., Kang, N., Toyofuku, W. M., & Scott, M. D. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.12.003 · Cited by 10
Firmal, P., Shah, V. K., Pant, R., & Chattopadhyay, S. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13126 · Cited by 10
Application of Bacterial Whole-Cell Biosensors in Health
Song, Y., Rampley, C. P. N., Chen, X., Du, F., Thompson, I. P., & Huang, W. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-23217-7_136 · Cited by 10
Windemuth, S. X., Hahn, J., You, J. H., Wang, Z., Ding, S., Tarrab, S., Coker, C., Leong, K. W., & Danino, T. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00333 · Cited by 9
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review
Zong, Z., Zeng, W., Li, Y., Wang, M., Cao, Y., Cheng, X., Jin, Z., Mao, S., & Zhu, X. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.07 · Cited by 9
New experimental therapies for glioblastoma: a review of preclinical research
Yuzhalin, A. E. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02105-w · Cited by 9
Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer
Shi, L., Xu, Y., & Feng, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07689-0 · Cited by 9
Current advances in microbial-based cancer therapies
Shahbaz, A., Mahmood, T., Javed, M. U., & Abbasi, B. H. (2023) · Medical Oncology · doi:10.1007/s12032-023-02074-x · Cited by 9
“FlaB Colon cancer Engineered FlaB from Vibrio vulnificus-secreting bacteria [37]”
BackgroundAdvances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Eskandari, A., Leow, T. C., Rahman, M. B. A., & Oslan, S. N. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01144-3 · Cited by 9
Chang, X., Liu, X., Wang, X., Ma, L., Liang, J., & Li, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1545334 · Cited by 9
Targeting toll-like receptors on T cells as a therapeutic strategy against tumors
Ding, R., Jiao, A., & Zhang, B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108708 · Cited by 9
[Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
Peng, Y., Luo, X.-M., & Chen, J.-Y. (2023) · 四川大学学报:医学版 · doi:10.12182/20230560502 · Cited by 9
Yoo, S. W., Nguyen, D.-H., Park, S., Lee, H., Lee, C., Lee, C., & Min, J. (2020) · Applied Sciences · doi:10.3390/app10030844 · Cited by 9
Self-citationMiyake, K., Kiyuna, T., Miyake, M., Kawaguchi, K., Yoon, S. N., Zhang, Z., Igarashi, K., Razmjooei, S., Wangsiricharoen, S., Murakami, T., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0016-7 · Cited by 9
“typhimurium A1-R has immense potential in curing recalcitrant cancers.(20) In conclusion, our CUP PDOX model identified CAR as the only active drug among the 4 drugs that were tested.”
BackgroundLim, D., Kim, H. K., Jeong, J., Jung, Y. S., Lee, S. E., Jang, H., Jung, S., Choi, H.-S., Rhee, J. H., Lee, S., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8050646 · Cited by 9
Self-citationPrecision tumor immunotherapy via a dual-gated macrophage–bacterial activation platform
Li, L., Wu, L., Qiao, L., Zhang, S., Luan, X., Qiu, J., Qiao, X., Li, C., Sun, Y., Wang, B., et al. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.09.013 · Cited by 8
Glutathione-responsive self-assembling peptide-coated Salmonella for antitumor therapy
Shen, J., Yongjie, Z., Li, T., Wu, X., Zheng, J. H., & Shi, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114547 · Cited by 8
Self-citationAdvances in delivery technologies-powered cancer vaccines
Huang, C., Wang, H., Luo, S., Yu, C., Zhang, L., & Zhu, D. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.014 · Cited by 8
“In contrast to the predominantly cellular immune responses triggered by TLR 4 agonists, TLR 5 agonists can rapidly initiate innate immune responses [75].”
Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Yu, K. L., & Shen, S. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115195 · Cited by 8
Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses
Harmak, Z., Kone, A.-S., Ghouzlani, A., Ghazi, B., & Badou, A. (2024) · Immune Network · doi:10.4110/in.2024.24.e40 · Cited by 8
Das, M., Kiruthiga, C., Shafreen, R. B., Nachammai, K. T., Selvaraj, C., & Kulanthaivel, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177436 · Cited by 8
Microbiome and the Hallmarks of Cancer
Bleich, R. M., & Arthur, J. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_1 · Cited by 8
Metadata
- Authors
- Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., Choy, H. E., Lee, S. E., Rhee, J. H., & Min, J.-J.
- Affiliations
- Chonnam National University (KR)
- City Of Hope National Medical Center (US)
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Rhee, Joon Haeng
- Min, Jung-Joon
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-02-08
- Volume
- 9
- Issue
- 376
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2586223583
- Cited by
- 588
- References
- 54
- Citations by year
- 2026: 76 · 2025: 81 · 2024: 85 · 2023: 73 · 2022: 71 · 2021: 65 · 2020: 55 · 2019: 34 · 2018: 30 · 2017: 18
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Pioneer Research Center Program (2015M3C1A3056410)
- Bio & Medical Technology Development Program (NRF-2014M3A9B5073747)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- NRF (2012-0006072)
- Ministry of Health and Welfare, Republic of Korea (HI14C0187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer immunotherapy, Salmonella typhimurium, tumor-targeting bacteria, intratumoral macrophages, M1 macrophage polarization, TLR ligands
- MeSH terms
- Animals, Colonic Neoplasms, Flagellin, Genetic Engineering, Humans, Immunotherapy, Macrophages, Male, Mice, Inbred C57BL, Mice, Nude, Neoplasm Metastasis, Neoplasms, Phenotype, Salmonella typhimurium, Colony Count, Microbial, Signal Transduction, Cell Polarity, Xenograft Model Antitumor Assays, HCT116 Cells, Toll-Like Receptor 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.